C-Met Modulators and Methods of Use
US-2015376133-A1 · Dec 31, 2015 · US
US10000792B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10000792-B2 |
| Application number | US-71008710-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 22, 2010 |
| Priority date | Dec 6, 2005 |
| Publication date | Jun 19, 2018 |
| Grant date | Jun 19, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates in general to cellular analysis tools and more particularly to methods for detecting or determining cyclic nucleotide concentrations in samples. Samples containing cyclic nucleotides may be contacted with a cyclic nucleotide-dependent protein kinase and a detection system which includes a substrate for the cyclic nucleotide-dependent protein kinase. The activities in cyclic nucleotide related pathways may be measured using the detection system.
Opening claim text (preview).
The invention claimed is: 1. A method for determining the presence or amount of endogenous cyclic nucleotide in a sample comprising a cell lysate, the method comprising: a) contacting a sample comprising a cell lysate which may contain endogenous cyclic nucleotide, with (I) a cyclic nucleotide-dependent protein kinase capable of being activated by the endogenous cyclic nucleotide, wherein said protein kinase is Protein Kinase A and (II) a detection system, the detection system comprising: i) a substrate capable of being phosphorylated by the cyclic nucleotide-dependent protein kinase; ii) a luciferase enzyme capable of utilizing ATP to generate a bioluminescent signal; and (iii) ATP; and b) detecting or measuring the bioluminescent signal thereby determining the presence or amount of the endogenous cyclic nucleotide present in the sample, wherein the cell lysate comprises the cellular debris and fluid that is released from a cell when the cell membrane is broken apart or lysed, wherein the endogenous cyclic nucleotide is cAMP. 2. The method of claim 1 , wherein the lysate is derived from eukaryotic cells. 3. The method of claim 1 , wherein the lysate is derived from mammalian cells. 4. The method of claim 1 , comprising determining the amount of the endogenous cyclic nucleotide in the sample based on the amount of change in the bioluminescent signal when compared to a standard curve of cyclic nucleotide concentration versus luminescence. 5. The method of claim 1 , wherein the sample comprises plasma membranes. 6. The method of claim 1 , wherein the substrate comprises SEQ ID NO:1. 7. The method of claim 1 , wherein the presence or amount of cAMP present is determined by comparing the bioluminescent signal to a standard curve of cAMP concentration versus luminescence. 8. The method of claim 1 , wherein the sample may contain adenylyl cyclase and further comprising determining from measuring the bioluminescent signal of step (b) the adenylyl cyclase activity present in the sample based on the presence or amount of the endogenous cyclic nucleotide. 9. The method of claim 1 , wherein the sample may contain G-protein coupled receptor and further comprising determining from measuring the bioluminescent signal of step (b) the activity of a G-protein coupled receptor present in the sample based on the presence or amount of the endogenous cyclic nucleotide. 10. The method of claim 1 , wherein the sample is incubated with the cyclic nucleotide-dependent protein kinase, the substrate and ATP prior to being contacted with the luciferase enzyme. 11. The method of claim 10 , wherein the substrate comprises kemptide.
HIV-1, HIV-2 · CPC title
G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH · CPC title
involving hormones {or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors} · CPC title
Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase · CPC title
involving luciferase · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.